Mr. Sitton is a partner in FBC's Corporate Department. Prior to joining FBC, he was a partner in the corporate practice group of the international firm Dentons in New York, where he led the firm's Israel practice.
Mr. Sitton utilizes his fluency in Hebrew and English, his familiarity with both American and Israeli business cultures and legal systems, and his broad network of global contacts to better advise Israelis doing business abroad and international clients doing business in Israel. He is experienced in structuring, negotiating and driving multiparty/multidisciplinary domestic and cross-border transactions.
While practicing in New York, Mr. Sitton’s practice focused on representation of investment funds and their portfolio companies in all aspects of business, including M&A, financing and investment, and equity holders' arrangements, as well as general corporate matters. He also represented sole proprietorships, corporations, partnerships, and LLCs in all phases of business organization, corporate and financial transactions, joint ventures, and day-to-day operations.
Mr. Sitton is active in several organizations promoting trade and cooperation between Israel and the United States.
Supreme Court of the United States, 2000
New York, 1999
Fordham University School of Law, New York (LL.M., International Business and Trade), 1998
College of Management (COMAS) School of Law, Israel (LL.B.), 1996
FBC represented Applied Immune Technologies Ltd. ("AIT"), a drug development company specializing in therapeutic applications for cancer and other autoimmune diseases, owned by Technion Research and Development Foundation Ltd., Technion Investment Opportunities Fund, Or...Raz Tepper & Ron Sitton | Jan 2016
FBC represented Bright Food (Group) Co., Ltd. and its affiliated entities in a financing transaction with Bank Hapoalim of approx. NIS 2 billion bank loan of Ap.Ms.Tn Holdings, Ltd. through which BFG holds its control interest in the Tnuva Group. The refinancing tran...Avraham Well & Ronald Lehmann & Ron Sitton & Carolyn Zeimer-Vigodny & Warren Wienburg | Apr 2015
FBC represented Bright Food (Group) Co., Ltd. and its affiliated entities in closing the purchase transaction of the control stake in the Tnuva Group from the Apax funds and Mivtach Shamir. The Sale and Purchase Agreement was signed in May 2014 and the closing of the t...Avraham Well & Boaz Noiman & Ron Sitton | Apr 2015
FBC advises Monsanto, in an investment in Evogene, a publicly traded Israeli company that develops genetic engineering technology, in its acquisition of Rosetta Green, a public Israeli company, and the Beelogics group of companies.Hagar Keren-Hackim & Amit Dat & Itiel Ben-Haim & Ronald Lehmann & Raz Tepper & Ron Sitton & Anat Shavit | Feb 2013